{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:24:17Z","timestamp":1773393857113,"version":"3.50.1"},"reference-count":15,"publisher":"American Chemical Society (ACS)","issue":"3","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-136530OB-I00"],"award-info":[{"award-number":["PID2022-136530OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACS Pharmacol. Transl. Sci."],"published-print":{"date-parts":[[2026,3,13]]},"DOI":"10.1021\/acsptsci.5c00818","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:46:48Z","timestamp":1770396408000},"page":"761-763","source":"Crossref","is-referenced-by-count":0,"title":["Masupirdine, a Selective Serotonin 5-HT\n                    <sub>6<\/sub>\n                    Receptor Antagonist for Alzheimer\u2019s Disease"],"prefix":"10.1021","volume":"9","author":[{"given":"Mireia","family":"Toledano-Pinedo","sequence":"first","affiliation":[{"name":"Institute of General Organic Chemistry (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Iriepa","sequence":"additional","affiliation":[{"name":"Universidad de Alcal\u00e1, Departamento de Qu\u00edmica Org\u00e1nica y Qu\u00edmica Inorg\u00e1nica, Instituto de Investigaci\u00f3n Qu\u00edmica \u201cAndr\u00e9s M. del R\u00edo\u201d (IQAR)","place":["Madrid, Spain"]},{"name":"Grupo DISCOBAC","place":["Toledo, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria de Castilla-La Mancha (IDISCAM)","place":["Toledo, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Mercedes","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Universidad Aut\u00f3noma de Madrid, Cantoblanco, 28049 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0690-0328","authenticated-orcid":true,"given":"Jos\u00e9","family":"Marco-Contelles","sequence":"additional","affiliation":[{"name":"Institute of General Organic Chemistry (CSIC), Juan de la Cierva 3, 28006 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01883-X"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01329-7"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.3390\/biom13020309"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01662"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000414"},{"key":"ref6\/cit6","unstructured":"Nirogi, R.; Mudigonda, K.; Dogiparti, D. K.; Jasti, V. Pharmaceutical Compositions of 5-HT6 Receptor Antagonist. US Patent US2021346374, 2021."},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-018-0618-4"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70098"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2024.11.029"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5c00653"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050694"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00663-w"},{"key":"ref13\/cit13","unstructured":"Nirogi, R.; Shinde, A. K.; Jayarajan, P.; Jetta, S.; Palacharla, R. C.; Pandey, S. K.; Mohammed, A. R.; Benade, V. S.; Goyal, V. K.; Bhyrapuneni, G.; Subramanian, R.; Ravula, J.; Jasti, V. Methods Using 5-HT6 Antagonists, Acetylcholinesterase Inhibitors and NMDA Receptor Antagonists for Treating Behavioral and Psychological Symptoms in Dementia Patients. World Patent WO2021111330, 2021."},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12307"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202500324"}],"container-title":["ACS Pharmacology &amp; Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsptsci.5c00818","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsptsci.5c00818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:10:53Z","timestamp":1773389453000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acsptsci.5c00818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,13]]}},"alternative-id":["10.1021\/acsptsci.5c00818"],"URL":"https:\/\/doi.org\/10.1021\/acsptsci.5c00818","relation":{},"ISSN":["2575-9108","2575-9108"],"issn-type":[{"value":"2575-9108","type":"print"},{"value":"2575-9108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}